Spruce Biosciences Inc (OQ:SPRB)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for SPRB within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 18th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 25/24 Mar 21/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -465,021 $0.755
Mar 20/24 Mar 20/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -359,979 $0.734
Mar 20/24 Mar 19/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -593,000 $0.755
Mar 20/24 Mar 18/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -842,020 $0.768
Mar 18/24 Mar 14/24 Charlton Ralph William III Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 106,400  
Mar 18/24 Mar 14/24 Gharib Samir M. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 154,000  
Mar 18/24 Mar 14/24 Szwarcberg Javier B. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 358,800  
Mar 18/24 Mar 14/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -1,912,316 $0.888
Jan 3/24 Dec 29/23 Charlton Ralph William III Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 9,361 $0.978
Jan 3/24 Dec 29/23 Gharib Samir M. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,255 $0.978
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SPRB within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET April 18th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 25/24 Mar 21/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -465,021 $0.755
Mar 20/24 Mar 20/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -359,979 $0.734
Mar 20/24 Mar 19/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -593,000 $0.755
Mar 20/24 Mar 18/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -842,020 $0.768
Mar 18/24 Mar 14/24 Charlton Ralph William III Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 106,400  
Mar 18/24 Mar 14/24 Gharib Samir M. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 154,000  
Mar 18/24 Mar 14/24 Szwarcberg Javier B. Direct Ownership Restricted Stock Units A - Grant, award or other under Rule 16b-3(d) 358,800  
Mar 18/24 Mar 14/24 Novo Holdings A/S Direct Ownership COMMON STOCK S - Open market or private sale -1,912,316 $0.888
Jan 3/24 Dec 29/23 Charlton Ralph William III Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 9,361 $0.978
Jan 3/24 Dec 29/23 Gharib Samir M. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 11,255 $0.978
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $SPRB

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Disc Medicine (OQ:IRON)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.